Cargando…

Adding Cases to the Study of Bucillamine-Associated Neural Epidermal Growth Factor-Like1-Positive Membranous Nephropathy

Detalles Bibliográficos
Autores principales:	Takahashi-Kobayashi, Mayumi, Usui, Joichi, Kawanishi, Kunio, Saito, Chie, Ebihara, Itaru, Yamagata, Kunihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403641/ https://www.ncbi.nlm.nih.gov/pubmed/37547509 http://dx.doi.org/10.1016/j.ekir.2023.05.032

Ejemplares similares

Response to Letter to the Editor entitled “Adding Cases to the Study of Bucillamine-Associated Neural Epidermal Growth Factor Like1-Positive Membranous Nephropathy”
por: Ueda, Hiroyuki
Publicado: (2023)

Peritubular capillary lesions in post-streptococcal acute glomerulonephritis
por: Usui, Joichi, et al.
Publicado: (2010)

Intramembranous electron-dense deposits in a nephrotic patient with mixed connective tissue disease: unusual response to corticosteroid therapy
por: Ebihara, Itaru, et al.
Publicado: (2008)

Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy
por: Kaga, Hajime, et al.
Publicado: (2022)

A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy
por: Nakajima, Shuhei, et al.
Publicado: (2023)

Levels of Soluble NKG2D Ligands and Cancer History in Patients Starting Hemodialysis
por: Nagai, Kei, et al.
Publicado: (2022)

Anti-glomerular Basement Membrane Glomerulonephritis During the First Trimester of Pregnancy
por: Kai, Hirayasu, et al.
Publicado: (2020)

Effectiveness of Plasmapheresis in a Patient with Anti-glomerular Basement Membrane Antibody Glomerulonephritis with Advanced Kidney Dysfunction
por: Usui, Toshiaki, et al.
Publicado: (2017)

Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling
por: Nishiya, Naoyuki, et al.
Publicado: (2019)

Bucillamine-Induced Membranous Nephropathy with Crescent Formation in a Patient with Rheumatoid Arthritis: Case Report and Literature Review
por: Manabe, Shun, et al.
Publicado: (2014)

Bucillamine‐induced interstitial pneumonitis
por: Nakamoto, Keitaro, et al.
Publicado: (2018)

The precise long-term outcomes of adult IgA nephropathy by mail questionnaires: Better renal survival compared to earlier cohort studies
por: Imai, Eri, et al.
Publicado: (2020)

Study protocol and baseline characteristics of newly induced dialysis patients: a prospective multi-center cohort study with a biological sample bank, the Ibaraki Dialysis Initiation Cohort (iDIC) study
por: Tawara-Iida, Takashi, et al.
Publicado: (2022)

Bucillamine‐induced yellow nail syndrome
por: Tanizaki, Ryutaro, et al.
Publicado: (2017)

Transcription factor 21 expression in injured podocytes of glomerular diseases
por: Usui, Joichi, et al.
Publicado: (2020)

IgA Nephropathy Caused by Unusual Polymerization of IgA1 with Aberrant N-Glycosylation in a Patient with Monoclonal Immunoglobulin Deposition Disease
por: Narimatsu, Yoshiki, et al.
Publicado: (2014)

Corticosteroids pulse therapy and oral corticosteroids therapy for IgA nephropathy patients with advanced chronic kidney disease: results of a multicenter, large-scale, long-term observational cohort study
por: Tsunoda, Ryoya, et al.
Publicado: (2018)

Mitochondrial DNA deletion-dependent podocyte injuries in Mito-miceΔ, a murine model of mitochondrial disease
por: Kaneko, Shuzo, et al.
Publicado: (2021)

Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study
por: Kawamura, Tetsuya, et al.
Publicado: (2017)

Age-dependent survival in rapidly progressive glomerulonephritis: A nationwide questionnaire survey from children to the elderly
por: Takahashi-Kobayashi, Mayumi, et al.
Publicado: (2020)

A Case of BOOP Developed during Bucillamine Treatment for Rheumatoid
por: Lee, Young Ho, et al.
Publicado: (2001)

Clinicopathologic Spectrum of Renal Lesions Following Anti-TNF-α Inhibitor Therapy: A Single Center Experience
por: Usui, Joichi, et al.
Publicado: (2023)

Bucillamine prevents cisplatin-induced ototoxicity through induction of glutathione and antioxidant genes
por: Kim, Se-Jin, et al.
Publicado: (2015)

Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank
por: Frank, Michael
Publicado: (2022)

A Case of Rheumatoid Arthritis with Bucillamine-Induced Yellow Nail Syndrome Initially Manifesting as Pulmonary Disease
por: Isozaki, Takeo, et al.
Publicado: (2010)

Bucillamine-Induced Pemphigus Vulgaris in a Patient with Rheumatoid Arthritis and Polymyositis Overlap Syndrome
por: Hur, Jin-Wuk, et al.
Publicado: (2006)

Hyperplasia of Lymphoid Follicles and Lymphangiectasia in the Parietal Pleura in Bucillamine-induced Yellow Nail Syndrome
por: Hase, Isano, et al.
Publicado: (2018)

Temporal Changes in Post-Infectious Glomerulonephritis in Japan (1976-2009)
por: Usui, Joichi, et al.
Publicado: (2016)

Nationwide Survey of Post-Transplant Glomerular Diseases, Based on the Japan Renal Biopsy Registry (J-RBR)
por: Usui, Joichi, et al.
Publicado: (2021)

HLA-DRB1*08:02 Is Associated with Bucillamine-Induced Proteinuria in Japanese Rheumatoid Arthritis Patients
por: Furukawa, Hiroshi, et al.
Publicado: (2014)

Microscopic papillary tumor in a renal needle biopsy specimen for IgA nephropathy
por: Neild, G. H., et al.
Publicado: (2011)

Prediction of early graft function after living donor kidney transplantation by quantifying the “nephron mass” using CT-volumetric software
por: Takahashi, Kazuhiro, et al.
Publicado: (2022)

Anti-PM/Scl Antibody-positive Systemic Sclerosis Complicated by Multiple Organ Involvement
por: Shimizu, Tatsuya, et al.
Publicado: (2020)

Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature
por: Fukada, Atsuki, et al.
Publicado: (2019)

Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature
por: Kalemci, Serdar, et al.
Publicado: (2019)

A Rare Case of Neural Epidermal Growth Factor-Like 1 Protein (NELL-1) Antigen-Associated Membranous Nephropathy
por: Mohamed Jiffry, Mohamed Zakee, et al.
Publicado: (2023)

Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Saito, Kosuke, et al.
Publicado: (2016)

Pembrolizumab-Associated Nerve Epidermal Growth Factor-Like 1 Membranous Nephropathy
por: Nimkar, Abhishek, et al.
Publicado: (2022)

Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature - Reply
por: Fukada, Atsuki, et al.
Publicado: (2019)

Fatal toxic epidermal necrolysis associated with sinomenine in a patient with primary membranous nephropathy
por: Li, Xue-xia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7gvpp9d3ansn8grs3td86bqt1h